ArticleRevista peruana de medicina experimental y salud publica2026
Characterization of dengue cases in a family medicine unit in Mexico.
Article in Revista peruana de medicina experimental y salud publica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The objective of this study was to describe the epidemiological and clinical characteristics of dengue cases treated at a family medicine unit in Guerrero, Mexico. A case series was conducted, including patients diagnosed with dengue between January and December 2023. Of a total of 596 cases, 91.8% presented with dengue without warning signs, 8.1% with warning signs, and 0.2% with severe dengue. Hospitalization was required for 2.7% of patients, and the case fatality rate was 0.2%. The most frequent symptoms were fever (98.2%), headache (79.7%), and myalgia (75.3%). Dengue serology was performed in 28.1% of cases, with a positivity rate of 37%. The clinical findings support its usefulness for timely diagnosis and therapeutic decision-making based on the severity of the illness; they also highlight the importance of early identification of warning signs by the population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.